Professor Lee Seunghoon of Seoul National University Hospital Receives Minister of SMEs Award for Venture Startup Contributions

[Asia Economy Reporter Myunghwan Lee] Seoul National University Hospital announced on the 28th that Professor Seunghoon Lee of the Department of Neurology received the Minister of SMEs and Startups Award at the '2022 Venture Startup Promotion Merit Awards Ceremony.'

Now in its 24th year, the Venture Startup Promotion Merit Awards is an event hosted by the Ministry of SMEs and Startups and organized by six institutions including the Korea Institute of Startup & Entrepreneurship Development to honor individuals who have contributed to the development of the venture industry and innovative growth. The application period from April to June saw a competition rate of 16.8:1, and the final winners were selected through a rigorous evaluation process including document screening, on-site inspections, and interviews.

Professor Lee, who founded the bio-venture company 'Senics Biotech' in 2016 and is developing nanozyme-related therapeutics, recently unveiled the subarachnoid hemorrhage treatment 'CX213' as well as the new drug 'CX201' targeting severe traumatic brain injury.

Professor Lee said, "I am pleased to be recognized for creating new value through dedicated development of nanozyme-based new drugs," adding, "I will contribute to the world's first commercialization of nanozymes through continuous research."

Meanwhile, Senics Biotech has established a total of four pipeline categories based on two proprietary platform technologies that ensure safe delivery, maximized efficacy, and structural stability of nanozymes.

This content was produced with the assistance of AI translation services.